Autopsy report · NCT00378300
The Effects of Probiotics in Atopic Dermatitis
Cause of deathFunding or business
“Inadequate funding to support this fellow-in-training initiated study.”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Na
- Sponsor
- University of California, Los Angeles
- Sponsor type
- University, hospital or other
- Conditions
- Atopic Dermatitis
- Interventions
- Oral Probiotics
- Participants
- 0
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Efficacy of Kerecis Omega 3 in Comparison to Clinical Standard Procedures
“Lack of funding to support the study” - Study of EQU-001 for Uncontrolled Focal Onset Seizures
“insufficient funding to complete the study” - Midodrine Use in Septic Shock
“No funding for the study; not enough staff” - Regulation of the Release of Inflammatory Mediators From Blood Leukocytes
“No funding for the study” - A Phase III Study of Re-Irradiation in Recurrent Glioblastoma
“This study will not be proceeding due to lack of funding from anticipated sources”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.